| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 13.78 | 3.3% | 51.3% |
| Total Income | 13.78 | 3.3% | 51.3% |
| Expenditure | 125.26 | 0.8% | 18.6% |
| PBT | — | ||
| Net Profit | -101.32 | 0.1% | 25.3% |
| OPM | — | ||
| NPM | — | ||
| EPS | -0.92 | 6.1% | 31.3% |
Intellia Therapeutics Announces Q3 2025 Results
04 May 2026 · 4 May, 7:44 am
Summary
Intellia Therapeutics, Inc. announced its financial results and business updates for the quarter ended September 30, 2025. The announcement was made in a press release dated November 6, 2025.
Informational and educational content only. Not investment advice.